CS0159Linafexorchenodeoxycholic acidCDCAmetabolic dysfunction-associated steatotic liver disease (MASLD)MASLD
…pathway, particularly through intervention with the FXR agonist CS0159, provides a novel therapeutic strategy and potential target for…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…pathway, particularly through intervention with the FXR agonist CS0159, provides a novel therapeutic strategy and potential target for…
…The Amsterdam UMC makes chenodeoxycholic acid (CDCA) capsules to treat their patients with the rare metabolic…
…ier integrity. Notably, accumulating primary bile acids such as chenodeoxycholic acid exacerbated aGVHD by enhancing the activation of T cells. Media…